The long-term course of panic disorder - An 11 year follow-up

Journal of Anxiety Disorders

Volumn 17, Issue 2, 2003, Pages 223-232

  Swoboda, Hemma ^a   Amering, M ^a   Windhaber, J ^a   Katschnig, H ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Disabilities; Follow up; Long term course; Panic disorder; Phobic avoidance

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISABILITY; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MALE; PANIC; PHOBIA; REMISSION; SUICIDE;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; ADULT; AUSTRALIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PANIC DISORDER; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 0037289155     PISSN: 08876185     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-6185(02)00183-4     Document Type: Article

References (19)

1. Agras S., Sylvester D., Oliveau D. The epidemiology of common fears and phobias. Comprehensive Psychiatry. 35:1969;517-521.
2. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (4th ed.). Washington, DC: APA.
3. Ballenger J.C., Burrows G.D., DuPont R.L., Lesser I.M., Noyes R. Jr., Pecknold J.C., Rifkin A., Swinson R.P. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Archives of General Psychiatry. 45:1988;413-421.
4. Cross-National Collaborative Panic Study Second Phase Investigators. (1992). Drug treatment of panic disorder: comparative efficacy of alprazolam, imipramine and placebo. British Journal of Psychiatry, 160, 191-202.
5. Davis C.E. The effect of regression to the mean in epidemiologic and clinical studies. Journal of Epidemiology. 104:1976;493-498.
6. Katschnig H., Amering M., Stolk J.M., Klerman G.L., Ballenger J.C., Briggs A., Buller R., Cassano G., Garvey M., Roth M., Solyom C. Long-term follow-up after a drug trial for panic disorder. British Journal of Psychiatry. 167:1995;487-494.
7. Katschnig H., Amering M. The long-term course of panic disorder and its predictors. Journal of Clinical Psychopharmacology. 18(Suppl. 2):1998;6S-11S.
8. Klerman G.L., Weissman M.M., Ouellette R., Johnson J., Greenwald S. Panic attacks in the community. Social morbidity and health care utilization. Journal of the American Medical Association. 256:1991;742-746.
9. Leon A.C., Shear M.K., Portera L., Klerman G.L. Assessing impairment in patients with panic disorder: the Sheehan Disability Scale. Social Psychiatry and Psychiatric Epidemiology. 27(2):1992;78-82.
10. Marks L.M., Lader M. Anxiety states (anxiety neurosis): a review. Journal of Nervous and Mental Disease. 156:1973;3-18.
11. Marks I.M., Matthews A.M. Brief standard self-rating for phobic patients. Behavior Research and Therapy. 17:1979;263-267.
12. Nelson, R. O. (1977). Methodological issues in assessment via self-monitoring. In: J. D. Cone & R. P. Hawkings (Eds.), Behavioral assessment: new directions in clinical psychology. New York: Brunner/Mazel.
13. Noyes R., Clancy L., Hoen K.P.R., Slymen D.J. The prognosis of anxiety neurosis. Archives of General Psychiatry. 37:1980;173-178.
14. Roy-Burne P.P., Cowley D.S. Course and outcome in panic disorder: a review of recent follow-up studies. Anxiety. 1:1995;151-160.
15. Shear M.K., Maser J.D. Standardized assessment for panic disorder research: a conference report. Archives of General Psychiatry. 51:1994;346-354.
16. Shear M.K. Treatment of panic and phobias. Current Opinion in Psychiatry. 9:1996;121-124.
17. Sheehan D.V., Sheehan K.E. The classification of anxiety and hysterical states. Journal of Clinical Psychopharmacology. 2:1982;235-243.
18. Sheehan, D. V. (1983). The anxiety disease. New York: Scribner.
19. Spitzer, R. L., & William, J. B. W. (1983). Structured Clinical Interview for DSM-III (SCID). New York: NY State Biometrics Research Department.